Zusammenfassung
Seit über 20 Jahren wird die orthotope Herztransplantation zur Therapie von Patienten mit terminaler Herzerkrankung eingesetzt. Die perioperative Betreuung dieser Patienten ist eine Herausforderung für den Anästhesisten. Zunächst muss es gelingen, einen Patienten mit terminaler Herzinsuffizienz, Herzrhythmusstörungen und oftmals multiplen Voroperationen sicher an die Herz-Lungen-Maschine anzuschließen. Danach ist selbst bei einer unproblematischen Durchführung der eigentlichen Transplantation und kurzer Ischämiezeit der Abgang von der Herz-Lungen-Maschine häufig erschwert. Der rechte Ventrikel des Spenderorgans ist in vielen Fällen nicht an den pulmonalen Gefäßwiderstand des Empfängers angepasst. Bei vorbestehender pulmonaler Hypertonie des Empfängers entwickelt sich oft eine akute Rechtsherzinsuffizienz. Zur Therapie des akuten Rechtsherzversagens gehören die Senkung des pulmonalen Gefäßwiderstands und die Verbesserung der rechtsventrikulären Pumpfunktion. Der Einsatz der transösophagealen Echokardiographie (TEE) ermöglicht die frühzeitige Diagnose und Therapiekontrolle des akuten Rechtsherzversagens. Darüber hinaus können wichtige Differenzialdiagnosen, wie beispielsweise ein Abknicken der pulmonalen Anastomose oder eine Klappeninsuffizienz im Spenderorgan (z. B. Trikuspidalinsuffizienz), erkannt werden. Neben der Betreung von Patienten, die sich einer Herztransplantation unterziehen, gehört auch die perioperative Versorgung von Patienten nach Herztransplantation zu den Aufgaben des Anästhesisten. Die Kenntnis der physiologischen und pharmakologischen Besonderheiten dieser Patientengruppe ist hierbei von entscheidender Bedeutung.
Abstract
Over the past 30 years, heart transplantation has evolved into a definitive therapy for patients with end-stage cardiomyopathy. However, perioperative management of patients undergoing heart transplantation remains a challenge for anesthesiologists. The presence of biventricular failure, arrhythmias and associated multisystem organ dysfunction may contribute to significant intraoperative hemodynamic instability prior to the initiation of cardiopulmonary bypass (CPB). Even after an uneventful transplantation, weaning from CPB may be difficult. Acute right ventricular failure can develop in the recipient secondary to pre-existing pulmonary hypertension. Treatment options frequently focus on therapeutic interventions directed towards decreasing pulmonary vascular resistance and improving right ventricular contractility. Intraoperative use of transesophageal echocardiography (TEE) enables the anesthesiologist to diagnose acute right ventricular failure early on and guide therapy. Concurrent pathology including kinking of the pulmonary artery anastomosis or valvular insufficiency in the transplanted heart can also be recognized and addressed. The number of patients undergoing cardiac transplantation is continually increasing. In addition, the use of more effective immunosuppressive agents has curtailed transplant rejection and permitted longer survival. Consequently, heart transplant recipients are more frequently presenting for non-cardiac surgical procedures. Thus, an understanding of physiological and pharmacological implications associated with heart transplantation is crucial for managing these patients in the perioperative period.
Literatur
Addonizio LJ, Gersony WM, Robbins RC et al. (1987) Elevated pulmonary vascular resistance and cardiac transplantation. Circulation 76:V52–55
Anyanwu AC, Rogers CA, Murday AJ (2002) Intrathoracic organ transplantation in the United Kingdom 1995–99: results from the UK cardiothoracic transplant audit. Heart 87:449–454
Arafa OE, Geiran OR, Andersen K, Fosse E, Simonsen S, Svennevig JL (2000) Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation. Ann Thorac Surg 70:1587–1593
Arrowood JA, Minisi AJ, Goudreau E, Davis AB, King AL (1997) Absence of parasympathetic control of heart rate after human orthotopic cardiac transplantation. Circulation 96:3492–3498
Aziz TM, Burgess MI, El-Gamel A, Campbell CS, Rahman AN, Deiraniya AK, Yonan NA (1999) Orthotopic cardiac transplantation technique: a survey of current practice. Ann Thorac Surg 68:1242–1246
Backman SB, Ralley FE, Fox GS (1993) Neostigmine produces bradycardia in a heart transplant patient. Anesthesiology 78:777–779
Backman SB, Stein RD, Ralley FE, Fox GS (1996) Neostigmine-induced bradycardia following recent vs remote cardiac transplantation in the same patient. Can J Anaesth 43:394–398
Baldwin JC, Anderson JL, Boucek MM, Bristow MR, Jennings B, Ritsch ME, Silverman NA (1993) 24th Bethesda conference: Cardiac transplantation. Task Force 2: Donor guidelines. J Am Coll Cardiol 22:15–20
Baldwin RT, Duncan JM, Frazier OH, Wilansky S (1991) Patent foramen ovale: a cause of hypoxemia in patients on left ventricular support. Ann Thorac Surg 52:865–867
Bando K, Konishi H, Komatsu K et al. (1993) Improved survival following pediatric cardiac transplantation in high-risk patients. Circulation 88:II218–223
Barnard CN (1967) The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 41:1271–1274
Barnard CN (1968) What we have learned about heart transplants. J Thorac Cardiovasc Surg 56:457–468
Barnard SP, Hasan A, Forty J, Hilton CJ, Dark JH (1995) Mechanical ventricular assistance for the failing right ventricle after cardiac transplantation. Eur J Cardiothorac Surg 9:297–299
Baumgartner WA, Traill TA, Cameron DE, Fonger JD, Birenbaum IB, Reitz BA (1989) Unique aspects of heart and lung transplantation exhibited in the 'domino-donor' operation. JAMA 261:3121–3125
Beebe DS, Shumway SJ, Maddock R (1994) Sinus arrest after intravenous neostigmine in two heart transplant recipients. Anesth Analg 78:779–782
Bengel FM, Ueberfuhr P, Schiepel N, Nekolla SG, Reichart B, Schwaiger M (2001) Effect of sympathetic reinnervation on cardiac performance after heart transplantation. N Engl J Med 345:731–738
Beniaminovitz A, Itescu S, Lietz K et al. (2000) Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. N Engl J Med 342:613–619
Bjerke RJ, Mangione MP (2001) Asystole after intravenous neostigmine in a heart transplant recipient. Can J Anaesth 48:305–307
Borel JF, Feurer C, Gubler HU, Stahelin H (1976) Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 6:468–475
Borel JF, Feurer C, Magnee C, Stahelin H (1977) Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology 32:1017–1025
Borow KM, Neumann A, Arensman FW, Yacoub MH (1989) Cardiac and peripheral vascular responses to adrenoceptor stimulation and blockade after cardiac transplantation. J Am Coll Cardiol 14:1229–1238
Bourge RC, Naftel DC, Costanzo-Nordin MR et al. (1993) Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant 12:549–562
Brandt M, Harringer W, Hirt SW, Walluscheck KP, Cremer J, Sievers HH, Haverich A (1997) Influence of bicaval anastomoses on late occurrence of atrial arrhythmia after heart transplantation. Ann Thorac Surg 64:70–72
Brunner-La Rocca HP, Weilenmann D, Bracht C, Carli S, Schlumpf M, Follath F, Kiowski W (1998) Relative frequency of functional sympathetic and parasympathetic reinnervation after heart transplantation. J Heart Lung Transplant 17:725–728
Bundesärztekammer (2001) Richtlinien für die Warteliste zur Herz-, Herz-Lungen- und Lungentransplantation (thorakale Organtransplantationen). Erste Fortschreibung 2001.http://www.bundesaerztekammer.de/30/Richtlinien/Richtidx/Organ/10Organtrans/30WarteHerz.html
Canivet JL, Defraigne JO, Demoulin JC, Limet R (1994) Mechanical flow obstruction after heart transplantation diagnosed by TEE. Ann Thorac Surg 58:890–891
Cannom DS, Graham AF, Harrison DC (1973) Electrophysiological studies in the denervated transplanted human heart. Response to trial pacing and atropine. Circ Res 23:268–278
Cannom DS, Rider AK, Sinson EB et al. (1973) Electrophysiological studies in the denervated transplanted human heart. II. Response to norepinephrine, isoproterenol and propanolol. Am J Cardiol 36:859–866
Cantin B, Wen P, Zhu D et al. (2001) Transplant coronary artery disease: a novel model independent of cellular alloimmune response. Circulation 104:2615–2619
Caparrelli DJ, Shake JG, Cattaneo SM 2nd, Chang BY, Baumgartner WA, Conte JV Jr, George P (2002) Heterotopic abdominal heart transplantation: a pilot study. Curr Opin Cardiol 17:145–151
Chatel D, Paquin S, Oroudji M, Provenchere S, Plantefeve G, Philip I (1999) Systolic anterior motion of the anterior mitral leaflet after heart transplantation. Anesthesiology 91:1535–1537
Chen EP, Bittner HB, Davis RD, Trigt P van (1997) Effects of nitric oxide after cardiac transplantation in the setting of recipient pulmonary hypertension. Ann Thorac Surg 63:1546–1555
Chen EP, Bittner HB, Davis RD, Trigt P van (1997) Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. Ann Thorac Surg 63:814–821
Chen EP, Bittner HB, Davis RD, Trigt P van (1997) Hemodynamic and inotropic effects of nitric oxide in pulmonary hypertension. J Surg Res 69:288–294
Chen EP, Bittner HB, Tull F, Craig D, Davis RD, Trigt P van (1997) Nitric oxide improves pulmonary vascular impedance, transpulmonary efficiency, and left ventricular filling in chronic pulmonary hypertension. J Thorac Cardiovasc Surg 113:849–857
Chen EP, Bittner HB, Davis RD, Trigt P van (1998) Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension. J Heart Lung Transplant 17:669–678
Chen EP, Craig DM, Bittner HB, Davis RD, Trigt P van (1998) Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertension. Circulation 97:1606–1612
Chen JM, Levin HR, Rose EA et al. (1996) Experience with right ventricular assist devices for perioperative right-sided circulatory failure. Ann Thorac Surg 61:305–310; discussion 311–313
Cheong KF, Choy JM (2000) Sevoflurane-fentanyl versus etomidate-fentanyl for anesthetic induction in coronary artery bypass graft surgery patients. J Cardiothorac Vasc Anesth 14:421–424
Colon R, Frazier OH, Kahan BD, Radovancevic B, Duncan JM, Lorber MI, Buren CT van (1988) Complications in cardiac transplant patients requiring general surgery. Surgery 103:32–38
Copeland JG, Emery RW, Levinson MM, Copeland J, McAleer MJ, Riley JE (1985) The role of mechanical support and transplantation in treatment of patients with end-stage cardiomyopathy. Circulation 72:II7–12
Costanzo-Nordin MR, O'Connell JB, Engelmeier RS, Moran JF, Scanlon PJ (1985) Dilated cardiomyopathy: functional status, hemodynamics, arrhythmias, and prognosis. Cathet Cardiovasc Diagn 11:445–453
Costard-Jackle A, Fowler MB (1992) Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 19:48–54
Dajani AS, Taubert KA, Wilson W et al. (1997) Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 277:1794–1801
Dajani AS, Taubert KA, Wilson W et al. (1997) Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation 96:358–366
Darrah WC, Sharpe MD, Guiraudon GM, Neal A (1997) Intraaortic balloon counterpulsation improves right ventricular failure resulting from pressure overload. Ann Thorac Surg 64:1718–1723; discussion 1723–1724
Del Rizzo DF, Menkis AH, Pflugfelder PW, Novick RJ, McKenzie FN, Boyd WD, Kostuk WJ (1999) The role of donor age and ischemic time on survival following orthotopic heart transplantation. J Heart Lung Transplant 18:310–319
Deng MC, De Meester JM, Smits JM, Heinecke J, Scheld HH (2000) Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group. BMJ 321:540–545
Dreyfus G, Jebara VA, Couetil JP, Carpentier A (1990) Kinking of the pulmonary artery: a treatable cause of acute right ventricular failure after heart transplantation. J Heart Transplant 9:575–576
Dunkman WB, Johnson GR, Carson PE, Bhat G, Farrell L, Cohn JN (1993) Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 87 [Suppl 6]:VI94–101
Edrich T, Shernan SK, Smith B, Eltzschig HK (2003) Usefulness of intraoperative epiaortic echocardiography to resolve discrepancy between transthoracic and transesophageal measurements of aortic valve gradient. Can J Anaesth 50:293–296
Ellenbogen KA, Thames MD, DiMarco JP, Sheehan H, Lerman BB (1990) Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity. Circulation 81:821–828
Eltzschig HK, Goetz AE, Schroeder TH, Ehlers R, Felbinger TW (2002) Transesophageal echocardiography: perioperative evaluation of valvular function. Anaesthesist 51:81–102
Eltzschig HK, Mihaljevic T, Byrne JG, Ehlers R, Smith B, Shernan SK (2002) Echocardiographic evidence of right ventricular remodeling after transplantation. Ann Thorac Surg 74:584–586
Eltzschig HK, Kallmeyer I, Mihaljevic T, Alapati S, Shernan SK (2003) A practical approach to a comprehensive epicardial echocardiographic examination. J Cardiothorac Vasc Anesth (in press)
Evans RW, Manninen DL, Garrison LP, Maier AM (1986) Donor availability as the primary determinant of the future of heart transplantation. JAMA 255:1892–1898
Falk RH, Foster E, Coats MH (1992) Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study. Am Heart J 123:136–142
Fazia RB, Mills RM, Conti CR, Staples ED (1996) Aortic valve endocarditis in an acutely rejecting orthotopic heart transplant recipient. Clin Cardiol 19:672–674
First International Congress on Cyclosporine. May 16–19, 1983, Houston, Texas. (1983) Transplant Proc 15:2207–3187
Fischer S, Strueber M, Haverich A (2000) Clinical cardiac and pulmonary transplantation: the Hannover experience. Clin Transplant:311–316
Fong SW, Qaqundah BY, Taylor WF (1974) Developmental patterns of ABO isoagglutinins in normal children correlated with the effects of age, sex, and maternal isoagglutinins. Transfusion 14:551–559
Frenk VE, Shernan SK, Eltzschig HK (2003) Epicardial echocardiography: diagnostic utility for evaluating aortic valve disease during coronary surgery. J Clin Anesth (in press)
Fullerton DA, Kirson LE, St Cyr JA, Albert JD, Whitman GJ (1993) The influence of respiratory acid-base status on adult pulmonary vascular resistance before and after cardiopulmonary bypass. Chest 103:1091–1095
Fullerton DA, Kirson LE, St Cyr JA, Kinnard T, Whitman GJ (1993) Influence of hydrogen ion concentration versus carbon dioxide tension on pulmonary vascular resistance after cardiac operation. J Thorac Cardiovasc Surg 106:528–536
Fullerton DA, McIntyre RC, Kirson LE, St Cyr JA, Whitman GJ, Grover FL (1996) Impact of respiratory acid-base status in patients with pulmonary hypertension. Ann Thorac Surg 61:696–701
Gao SZ, Schroeder JS, Hunt SA, Billingham ME, Valantine HA, Stinson EB (1989) Acute myocardial infarction in cardiac transplant recipients. Am J Cardiol 64:1093–1097
Ghignone M, Girling L, Prewitt RM (1984) Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology 60:132–135
Gieraerts R, Schertz C, Ghignone M (1989) Right ventricular failure after heart transplantation caused by a kink in the pulmonary artery anastomosis. J Cardiothorac Anesth 3:470–472
Girard C, Fargnoli JM, Godin-Ribuot D, Dutheil V, Maitrasse B, Girardet P, Arvieux CC (1996) Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension. J Heart Lung Transplant 15:700–708
Goldstein DJ, Oz MC, Rose EA (1998) Implantable left ventricular assist devices. N Engl J Med 339:1522–1533
Grande AM, Rinaldi M, D'Armini AM et al. (2000) Orthotopic heart transplantation: standard versus bicaval technique. Am J Cardiol 85:1329–1333
Grant SC, Khan MA, Faragher EB, Yonan N, Brooks NH (1995) Atrial arrhythmias and pacing after orthotopic heart transplantation: bicaval versus standard atrial anastomosis. Br Heart J 74:149–153
Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE (1989) Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561–3566
Greilich PE, Carr ME, Carr SL, Chang AS (1995) Reductions in platelet force development by cardiopulmonary bypass are associated with hemorrhage. Anesth Analg 80:459–465
Greilich PE, Brouse CF, Beckham J, Jessen ME, Martin EJ, Carr ME (2002) Reductions in platelet contractile force correlate with duration of cardiopulmonary bypass and blood loss in patients undergoing cardiac surgery. Thromb Res 105:523–529
Gridelli B, Remuzzi G (2000) Strategies for making more organs available for transplantation. N Engl J Med 343:404–410
Grondin CM, Pomar JL, Hebert Y, Bosch X, Santos JM, Enjalbert M, Campeau L (1984) Reoperation in patients with patent atherosclerotic coronary vein grafts. A different approach to a different disease. J Thorac Cardiovasc Surg 87:379–385
Halle AA, Di Sciascio G, Massin EK et al. (1995) Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 26:120–128
Hillman ND, Cheifetz IM, Craig DM, Smith PK, Ungerleider RM, Meliones JN (1997) Inhaled nitric oxide, right ventricular efficiency, and pulmonary vascular mechanics: selective vasodilation of small pulmonary vessels during hypoxic pulmonary vasoconstriction. J Thorac Cardiovasc Surg 113:1006–1013
Hoffmeister KM, Felbinger TW, Falet H et al. (2003) The clearance mechanism of chilled blood platelets. Cell 112:87–97
Hosenpud JD (1999) Coronary artery disease after heart transplantation and its relation to cytomegalovirus. Am Heart J 138:S469–472
Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ (2001) The Registry of the International Society for Heart and Lung Transplantation: eighteenth Official Report-2001. J Heart Lung Transplant 20:805–815
Huisman AM, Schalm SW, Simoons ML, Laird-Meeter K, Weimar W (1989) Disturbed liver function in heart transplantation candidates: two case reports. Neth J Med 35:33–37
Hunt BJ, Sack D, Amin S, Yacoub MH (1992) The perioperative use of blood components during heart and heart-lung transplantation. Transfusion 32:57–62
Jacquet L, Ziady G, Stein K, Griffith B, Armitage J, Hardesty R, Kormos R (1990) Cardiac rhythm disturbances early after orthotopic heart transplantation: prevalence and clinical importance of the observed abnormalities. J Am Coll Cardiol 16:832–837
Kapadia SR, Ziada KM, L'Allier PL et al. (2000) Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging. J Heart Lung Transplant 19:167–172
Karck M, Haverich A (1994) Heart transplantation under coumarin therapy: friend or foe? Eur J Anaesthesiol 11:475–479
Klima UP, Guerrero JL, Vlahakes GJ (1999) Myocardial perfusion and right ventricular function. Ann Thorac Cardiovasc Surg 5:74–80
Kunst H, Paruchuru PK, Madden B (2001) Bacterial endocarditis: a rare complication following orthotopic cardiac transplantation. J Heart Lung Transplant 20:483–485
Laffel G, Barnett A, Finkelstein S, Kaye M (1992) The relation between experience and outcome in heart transplantation. N Engl J Med 327:1220–1225
Langer F, Wendler O, Wilhelm W, Tscholl D, Schafers HJ (2001) Treatment of a case of acute right heart failure by inhalation of iloprost, a long-acting prostacyclin analogue. Eur J Anaesthesiol 18:770–773
Levy JH, Bailey JM, Deeb GM (2002) Intravenous milrinone in cardiac surgery. Ann Thorac Surg 73:325–330
Lower RR, Stofer RC, Shumway NE (1961) Homovital transplantation of the heart. J Thorac Cardiovasc Surg 41:196–204
Luke RG (1991) Mechanism of cyclosporine-induced hypertension. Am J Hypertens 4:468–471
Lurie KG, Bristow MR, Reitz BA (1983) Increased beta-adrenergic receptor density in an experimental model of cardiac transplantation. J Thorac Cardiovasc Surg 86:195–201
Mancini D (1997) Surgically denervated cardiac transplant. Rewired or permanently unplugged? Circulation 96:6–8
Marchena E, Futterman L de, Wozniak P, Madrid W, Mitrani A, Myerburg RJ, Bolooki H (1989) Pulmonary artery torsion: a potentially lethal complication after orthotopic heart transplantation. J Heart Transplant 8:499–502
Mercat A, Diehl JL, Meyer G, Teboul JL, Sors H (1999) Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med 27:540–544
Milano CA, Patel VS, Smith PK, Smith MS (2002) Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation. J Heart Lung Transplant 21:1127–1130
Miniati DN, Robbins RC (2001) Techniques in orthotopic cardiac transplantation: a review. Cardiol Rev 9:131–136
Miniati DN, Robbins RC (2002) Heart transplantation: a thirty-year perspective. Annu Rev Med 53:189–205
Miyamoto Y, Curtiss EI, Kormos RL, Armitage JM, Hardesty RL, Griffith BP (1990) Bradyarrhythmia after heart transplantation. Incidence, time course, and outcome. Circulation 82:IV313–317
Molloy WD, Lee KY, Girling L, Schick U, Prewitt RM (1984) Treatment of shock in a canine model of pulmonary embolism. Am Rev Respir Dis 130:870–874
Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012
Morris D, Mulvihill D, Lew WY (1987) Risk of developing complete heart block during bedside pulmonary artery catheterization in patients with left bundle-branch block. Arch Intern Med 147:2005–2010
Morrow WR, Naftel D, Chinnock R et al. (1997) Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group. J Heart Lung Transplant 16:1255–1266
Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, the Multicenter Automatic Defibrillator Implantation Trial II Investigators (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883
Mudge GH, Goldstein S, Addonizio LJ et al. (1993) 24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization. J Am Coll Cardiol 22:21–31
Myles PS, Leong CK, Weeks AM et al. (1997) Early hemodynamic effects of left atrial administration of epinephrine after cardiac transplantation. Anesth Analg 84:976–981
Organspende und Transplantation in Deutschland (2000) Deutsche Stiftung Organtransplantation
Ouseph R, Stoddard MF, Lederer ED (1997) Patent foramen ovale presenting as refractory hypoxemia after heart transplantation. J Am Soc Echocardiogr 10:973–976
Ozdogan E, Banner N, Fitzgerald M, Musumeci F, Khaghani A, Yacoub M (1990) Factors influencing the development of hypertension after heart transplantation. J Heart Transplant 9:548–553
Pae WE, Aufiero TX, Weldner PW, Miller CA, Pierce WS (1994) Aprotinin therapy for insertion of ventricular assist devices for staged heart transplantation. J Heart Lung Transplant 13:811–816
Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526
Prendergast TW, Furukawa S, Beyer AJ, Eisen HJ, McClurken JB, Jeevanandam V (1996) Defining the role of aprotinin in heart transplantation. Ann Thorac Surg 62:670–674
Priola DV, Spurgeon HA (1977) Cholinergic sensitivity of the denervated canine heart. Circ Res 41:600–606
Qi AZ, Tuna IC, Gornick CC et al. (1987) Potentiation of cardiac electrophysiologic effects of verapamil after autonomic blockade or cardiac transplantation. Circulation 75:888–893
Rajek A, Pernerstorfer T, Kastner J et al. (2000) Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E(1) during heart transplantation. Anesth Analg 90:523–530
Rakhit A, Nurko S, Gauvreau K, Mayer JE, Blume ED (2002) Gastrointestinal complications after pediatric cardiac transplantation. J Heart Lung Transplant 21:751–759
Rich S, Gubin S, Hart K (1990) The effects of phenylephrine on right ventricular performance in patients with pulmonary hypertension. Chest 98:1102–1106
Rothman SA, Jeevanandam V, Combs WG et al. (1996) Eliminating bradyarrhythmias after orthotopic heart transplantation. Circulation 94:II278–282
Sablotzki A, Czeslick E, Schubert S et al. (2002) Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension. [L'iloprost ameliore l'hemodynamique chez des malades souffrant d'insuffisance cardiaque chronique et d'hypertension arterielle pulmonaire]. Can J Anaesth 49:1076–1080
Sablotzki A, Hentschel T, Gruenig E et al. (2002) Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance. Eur J Cardiothorac Surg 22:746–752
Scherrer U, Vissing S, Morgan B et al. (1990) Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 323:693–699
Scherrer U, Vissing S, Morgan BJ, Hanson P, Victor RG (1990) Vasovagal syncope after infusion of a vasodilator in a heart-transplant recipient. N Engl J Med 322:602–604
Schroeder JS, Gao S-Z, Alderman EL et al. (1993) A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med 328:164–170
Schulman LL, Smith CR, Drusin R, Rose EA, Enson Y, Reemtsma K (1987) Patent foramen ovale complicating heart transplantation. A window on posttransplantation hemodynamics. Chest 92:569–572
Shah KB, Rao TL, Laughlin S, El-Etr AA (1984) A review of pulmonary artery catheterization in 6,245 patients. Anesthesiology 61:271–275
Shapira Y, Porter A, Wurzel M, Vaturi M, Sagie A (1998) Evaluation of tricuspid regurgitation severity: echocardiographic and clinical correlation. J Am Soc Echocardiogr 11:652–659
Shumway NE, Dong E, Stinson EB (1969) Surgical aspects of cardiac transplantation in man. Bull N Y Acad Med 45:387–393
Sievers HH, Weyand M, Kraatz EG, Bernhard A (1991) An alternative technique for orthotopic cardiac transplantation, with preservation of the normal anatomy of the right atrium. Thorac Cardiovasc Surg 39:70–72
Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391–394
Spray TL (1998) Use of aprotinin in pediatric organ transplantation. Ann Thorac Surg 65:S71–73; discussion S74–76
Srivastava R, Curtis M, Hendrickson S, Burns WH, Hosenpud JD (1999) Strain specific effects of cytomegalovirus on endothelial cells: implications for investigating the relationship between CMV and cardiac allograft vasculopathy. Transplantation 68:1568–1573
Starling RC, Cody RJ (1990) Cardiac transplant hypertension. Am J Cardiol 65:106–111
Steed DL, Brown B, Reilly JJ, Peitzman AB, Griffith BP, Hardesty RL, Webster MW (1985) General surgical complications in heart and heart-lung transplantation. Surgery 98:739–745
Stewart MJ, Huwez F, Richens D, Naik S, Wheatley DJ (1996) Infective endocarditis of the tricuspid valve in an orthotopic heart transplant recipient. J Heart Lung Transplant 15:646–649
Stinson EB, Dong E, Iben AB, Shumway NE (1969) Cardiac transplantation in man. 3. Surgical aspects. Am J Surg 118:182–187
Stobierska-Dzierzek B, Awad H, Michler RE (2001) The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 38:923–931
Taylor AJ, Bergin JD (1995) Cardiac transplantation for the cardiologist not trained in transplantation. Am Heart J 129:578–592
Thomson JG (1969) Production of severe athero in a transplanted human heart. Lancet 2:1088–1092
Tribouilloy CM, Enriquez-Sarano M, Bailey KR, Tajik AJ, Seward JB (2000) Quantification of tricuspid regurgitation by measuring the width of the vena contracta with Doppler color flow imaging: a clinical study. J Am Coll Cardiol 36:472–478
Uberfuhr P, Reichart B, Welz A et al. (1982) Report on a successful orthotopic cardiac transplantation in Germany. Klin Wochenschr 60:1435–1442
Uretsky BF (1990) Physiology of the transplanted heart. Cardiovasc Clin 20:23–56
Uretsky BF, Murali S, Reddy PS et al. (1987) Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 76:827–834
Verani MS, George SE, Leon CA et al. (1988) Systolic and diastolic ventricular performance at rest and during exercise in heart transplant recipients. J Heart Transplant 7:145–151
Vlahakes GJ, Turley K, Hoffman JI (1981) The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 63:87–95
Wadsworth R, Littler C (1996) Cardiac standstill, pulmonary artery catheterisation and left bundle branch block. Anaesthesia 51:97
Wahba A, Rothe G, Lodes H, Barlage S, Schmitz G (2001) The influence of the duration of cardiopulmonary bypass on coagulation, fibrinolysis and platelet function. Thorac Cardiovasc Surg 49:153–156
West LJ, Pollock-Barziv SM, Dipchand AI et al. (2001) ABO-incompatible heart transplantation in infants. N Engl J Med 344:793–800
Wittwer T, Pethig K, Struber M et al. (2001) Aerosolized iloprost for severe pulmonary hypertension as a bridge to heart transplantation. Ann Thorac Surg 71:1004–1006
Wittwer T, Franke U, Wahlers T (2002) Impact of aerosolized prostacyclin analog for severe pulmonary hypertension in thoracic organ transplantation. J Thorac Cardiovasc Surg 124:211–213
Yusuf S, Theodoropoulos S, Mathias CJ, Dhalla N, Wittes J, Mitchell A, Yacoub M (1987) Increased sensitivity of the denervated transplanted human heart to isoprenaline both before and after beta-adrenergic blockade. Circulation 75:696–704
Zwissler B (2000) Acute right heart failure. Etiology—pathophysiology—diagnosis—therapy. Anaesthesist 49:788-808
Zwissler B (2002) Inhaled vasodilators. Anaesthesist 51:603–624
Zwissler B, Rank N, Jaenicke U et al. (1995) Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass. Anesthesiology 82:1512–1516
Zwissler B, Welte M, Habler O, Kleen M, Messmer K (1995) Effects of inhaled prostacyclin as compared with inhaled nitric oxide in a canine model of pulmonary microembolism and oleic acid edema. J Cardiothorac Vasc Anesth 9:634–640
Zwissler B, Kemming G, Habler O et al. (1996) Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med 154:1671–1677
Zwissler B, Forst H, Messmer K (1998) Influence of positive end-expiratory pressure ventilation (PEEP) on left ventricular pattern of contraction in experimental ARDS. Eur J Med Res 3:231–240
Danksagung
Wir danken der kardioanästhesiologischen Abteilung des Brigham and Women's Hospitals, Harvard Medical School in Boston für die Bereitstellung des umfangreichen Bildarchivs, insbesondere Joe Scott und James Bell sowie Klaus-Jürgen Eltzschig für die Erstellung der Zeichnungen zur bikavalen Technik der orthotopen Herztransplantationen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eltzschig, H.K., Zwissler, B. & Felbinger, T.W. Perioperative Aspekte der Herztransplantation. Anaesthesist 52, 678–689 (2003). https://doi.org/10.1007/s00101-003-0556-1
Issue Date:
DOI: https://doi.org/10.1007/s00101-003-0556-1